IMMUNOVANT, INC.

Profile

Company Names

IMMUNOVANT, INC.

Addresses

320 WEST 37TH STREET, NEW YORK, NY 10018

Phone Numbers

917-580-3099

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$450,000,000.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2025-01-15 
$450,000,000.00 
$450,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EVA RENEE 
 
BARNETT 
EXECUTIVE OFFICER
IMMUNOVANT, INC.
ANDREW 
 
FROMKIN 
DIRECTOR
TARVEDA THERAPEUTICS, INC.   |  IMMUNOVANT, INC.
MICHAEL 
 
GEFFNER 
EXECUTIVE OFFICER
IMMUNOVANT, INC.
MELANIE 
 
GLORIA 
EXECUTIVE OFFICER
IMMUNOVANT, INC.
DOUGLAS 
 
HUGHES 
DIRECTOR
KALERA MEDICAL, INC.   |  CALYXO, INC.   |  IMMUNOVANT, INC.
BILL 
 
MACIAS 
EXECUTIVE OFFICER
IMMUNOVANT, INC.
GEORGE 
 
MIGAUSKY 
DIRECTOR
IMMUNOVANT, INC.
ATUL 
 
PANDE 
DIRECTOR
IMMUNOVANT, INC.
PETE 
 
SALZMANN 
EXECUTIVE OFFICER, DIRECTOR
IMMUNOVANT, INC.
JAY 
 
STOUT 
EXECUTIVE OFFICER
IMMUNOVANT, INC.
FRANK 
 
TORTI 
DIRECTOR
CERECOR INC.   |  GALERA THERAPEUTICS, INC.   |  TARVEDA THERAPEUTICS, INC.   |  ORPHOMED, INC.   |  EARGO, INC.   |  XOC PHARMACEUTICALS, INC.   |  EARLENS CORP   |  ARBUTUS BIOPHARMA CORP   |  IMMUNOVANT, INC.
CHRISTOPHER 
 
VAN TUYL 
EXECUTIVE OFFICER
IMMUNOVANT, INC.
ERIC 
 
VENKER 
DIRECTOR
ARBUTUS BIOPHARMA CORP   |  IMMUNOVANT, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-01-21
D
Link
PHARMACEUTICALS 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2025-01-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#